The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.

Cyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in the extracellular space by inflammatory cells and upon cell death. The presence of CyPA in patients with non-ischemic cardiomyopathy is asso...

Full description

Bibliographic Details
Main Authors: David Heinzmann, Anna Bangert, Anna-Maria Müller, Saskia N I von Ungern-Sternberg, Frederic Emschermann, Tanja Schönberger, Madhumita Chatterjee, Andreas F Mack, Karin Klingel, Reinhard Kandolf, Miroslav Malesevic, Oliver Borst, Meinrad Gawaz, Harald F Langer, Hugo Katus, Gunter Fischer, Andreas E May, Ziya Kaya, Peter Seizer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4404136?pdf=render
_version_ 1828792769789820928
author David Heinzmann
Anna Bangert
Anna-Maria Müller
Saskia N I von Ungern-Sternberg
Frederic Emschermann
Tanja Schönberger
Madhumita Chatterjee
Andreas F Mack
Karin Klingel
Reinhard Kandolf
Miroslav Malesevic
Oliver Borst
Meinrad Gawaz
Harald F Langer
Hugo Katus
Gunter Fischer
Andreas E May
Ziya Kaya
Peter Seizer
author_facet David Heinzmann
Anna Bangert
Anna-Maria Müller
Saskia N I von Ungern-Sternberg
Frederic Emschermann
Tanja Schönberger
Madhumita Chatterjee
Andreas F Mack
Karin Klingel
Reinhard Kandolf
Miroslav Malesevic
Oliver Borst
Meinrad Gawaz
Harald F Langer
Hugo Katus
Gunter Fischer
Andreas E May
Ziya Kaya
Peter Seizer
author_sort David Heinzmann
collection DOAJ
description Cyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in the extracellular space by inflammatory cells and upon cell death. The presence of CyPA in patients with non-ischemic cardiomyopathy is associated with poor clinical prognosis. Here, we investigated the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis using the strictly extracellular CyPA-inhibitor MM284. Since A/J mice develop severe inflammation and fibrosis after immunization with murine cardiac troponin I (mcTn I), we used this model to analyze the effects of an extracellular CyPA inhibition. As extracellular CyPA-inhibitor we used the recently described CsA-derivate MM284. In vitro studies confirmed that MM284 inhibits CyPA-induced monocytic migration and adhesion. A/J mice immunized with mcTnI were treated with MM284 or vehicle every second day. After 28 days, we found a considerable reduction of myocardial injury and fibrosis. Further analysis revealed a reduced myocardial presence of T-cells and macrophages compared to control treated animals. Whereas MMP-9 expression was reduced significantly by MM284, we observed no significant reduction of inflammatory cytokines such as IL-6 or TNFα. Extracellular CyPA plays an important role in autoimmune myocarditis for myocardial damage and fibrosis. Our data suggest a new pharmacological approach for the treatment of myocardial inflammation and reduction of cardiac fibrosis by inhibition of extracellular CyPA.
first_indexed 2024-12-12T03:14:29Z
format Article
id doaj.art-440cc1ea6f344efc967edec434a9f492
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T03:14:29Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-440cc1ea6f344efc967edec434a9f4922022-12-22T00:40:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012460610.1371/journal.pone.0124606The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.David HeinzmannAnna BangertAnna-Maria MüllerSaskia N I von Ungern-SternbergFrederic EmschermannTanja SchönbergerMadhumita ChatterjeeAndreas F MackKarin KlingelReinhard KandolfMiroslav MalesevicOliver BorstMeinrad GawazHarald F LangerHugo KatusGunter FischerAndreas E MayZiya KayaPeter SeizerCyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in the extracellular space by inflammatory cells and upon cell death. The presence of CyPA in patients with non-ischemic cardiomyopathy is associated with poor clinical prognosis. Here, we investigated the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis using the strictly extracellular CyPA-inhibitor MM284. Since A/J mice develop severe inflammation and fibrosis after immunization with murine cardiac troponin I (mcTn I), we used this model to analyze the effects of an extracellular CyPA inhibition. As extracellular CyPA-inhibitor we used the recently described CsA-derivate MM284. In vitro studies confirmed that MM284 inhibits CyPA-induced monocytic migration and adhesion. A/J mice immunized with mcTnI were treated with MM284 or vehicle every second day. After 28 days, we found a considerable reduction of myocardial injury and fibrosis. Further analysis revealed a reduced myocardial presence of T-cells and macrophages compared to control treated animals. Whereas MMP-9 expression was reduced significantly by MM284, we observed no significant reduction of inflammatory cytokines such as IL-6 or TNFα. Extracellular CyPA plays an important role in autoimmune myocarditis for myocardial damage and fibrosis. Our data suggest a new pharmacological approach for the treatment of myocardial inflammation and reduction of cardiac fibrosis by inhibition of extracellular CyPA.http://europepmc.org/articles/PMC4404136?pdf=render
spellingShingle David Heinzmann
Anna Bangert
Anna-Maria Müller
Saskia N I von Ungern-Sternberg
Frederic Emschermann
Tanja Schönberger
Madhumita Chatterjee
Andreas F Mack
Karin Klingel
Reinhard Kandolf
Miroslav Malesevic
Oliver Borst
Meinrad Gawaz
Harald F Langer
Hugo Katus
Gunter Fischer
Andreas E May
Ziya Kaya
Peter Seizer
The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
PLoS ONE
title The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
title_full The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
title_fullStr The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
title_full_unstemmed The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
title_short The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
title_sort novel extracellular cyclophilin a cypa inhibitor mm284 reduces myocardial inflammation and remodeling in a mouse model of troponin i induced myocarditis
url http://europepmc.org/articles/PMC4404136?pdf=render
work_keys_str_mv AT davidheinzmann thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT annabangert thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT annamariamuller thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT saskianivonungernsternberg thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT fredericemschermann thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT tanjaschonberger thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT madhumitachatterjee thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT andreasfmack thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT karinklingel thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT reinhardkandolf thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT miroslavmalesevic thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT oliverborst thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT meinradgawaz thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT haraldflanger thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT hugokatus thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT gunterfischer thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT andreasemay thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT ziyakaya thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT peterseizer thenovelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT davidheinzmann novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT annabangert novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT annamariamuller novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT saskianivonungernsternberg novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT fredericemschermann novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT tanjaschonberger novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT madhumitachatterjee novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT andreasfmack novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT karinklingel novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT reinhardkandolf novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT miroslavmalesevic novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT oliverborst novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT meinradgawaz novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT haraldflanger novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT hugokatus novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT gunterfischer novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT andreasemay novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT ziyakaya novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis
AT peterseizer novelextracellularcyclophilinacypainhibitormm284reducesmyocardialinflammationandremodelinginamousemodeloftroponiniinducedmyocarditis